These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14958227)

  • 21. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 22. [DURATION OF LIFE OF PROCONVERTIN (FACTOR VII)].
    JOSSO F; PROU WARTELLE O; MENACHE D
    Nouv Rev Fr Hematol; 1964; 4():572-5. PubMed ID: 14189008
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of oral and intravenous administration of vitamins K on the prothrombin and proconvertin levels of cholecystnephrostomized dogs.
    FISHER LM; JAQUES LB; MILLAR GJ
    Can J Biochem Physiol; 1956 Sep; 34(5):1039-51. PubMed ID: 13364731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemorrhagic diathesis caused by factor VII (proconvertin) deficiency].
    LORIE IuI; ORLOVA LD
    Probl Oncol; 1961 Mar; 6():22-30. PubMed ID: 13763551
    [No Abstract]   [Full Text] [Related]  

  • 25. [Constitutionally low blood levels of proconvertin].
    CHEVALLIER P; BERNARD J; BILSKIPASQUIER G; SAMAMA M; CERF P
    Bull Mem Soc Med Hop Paris; 1955 Jun 17-24; 71(19-20):679-92. PubMed ID: 13240477
    [No Abstract]   [Full Text] [Related]  

  • 26. [FUNCTIONAL RELATION BETWEEN ERYTHROPLASTIN (ERYTHROCYTE COAGULANT FACTOR) AND PLASMA FACTORS: PROACCELERIN (V), PROCONVERTIN (VII) AND STUART FACTOR(X)].
    GAERTNER H; CAEN J
    Acta Physiol Pol; 1964; 15():237-43. PubMed ID: 14227143
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital deficiency of proconvertin: a clinical and laboratory report.
    MILLER SP
    Blood; 1959 Dec; 14():1322-38. PubMed ID: 14422581
    [No Abstract]   [Full Text] [Related]  

  • 28. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.
    HOUGIE C; BARROW EM; GRAHAM JB
    J Clin Invest; 1957 Mar; 36(3):485-96. PubMed ID: 13406063
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of two cases of proconvertin dificiency].
    MARCINIAKOWNA E
    Postepy Hig Med Dosw; 1959; 13():307-10. PubMed ID: 14420924
    [No Abstract]   [Full Text] [Related]  

  • 30. A CLINICAL AND FAMILY STUDY OF HEREDITARY PROCONVERTIN (FACTOR VII) DEFICIENCY.
    HALL CA; RAPAPORT SI; AMES SB; DEGROOT JA
    Am J Med; 1964 Aug; 37():172-81. PubMed ID: 14206751
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombo-embolism in patients with total proconvertin (factor VII) deficency. A report on two cases.
    GODAL HC; MADSEN K; MEYER RN
    Acta Med Scand; 1962 Mar; 171():325-7. PubMed ID: 13899384
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood coagulation in pregnancy: proconvertin and prothrombin, and the hypercoagulable state.
    ALEXANDER B; MEYERS L; KENNY J; GOLDSTEIN R; GUREWICH V; GRINSPOON L
    N Engl J Med; 1956 Feb; 254(8):358-63. PubMed ID: 13288790
    [No Abstract]   [Full Text] [Related]  

  • 34. STUDIES ON PROCONVERTIN (FACTOR VII). 8. THE SPECIES SPECIFICITY OF FACTOR VII.
    PRYDZ H; FOSSEN RA
    Scand J Clin Lab Invest; 1965; 17():218-22. PubMed ID: 14316464
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial purification of human prothrombin and proconvertin: their characteristics and interaction.
    LEWIS JH; FERGUSON JH
    J Clin Invest; 1953 Oct; 32(10):915-21. PubMed ID: 13096556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 37. [Erythroplastin: coagulant factor of the erythrocytes. Relation to proaccelerin, proconvertin and the Stuart factor].
    GAERTNER HA; CAEN J
    Pathol Biol; 1961 Sep; 9():1735-8. PubMed ID: 13896158
    [No Abstract]   [Full Text] [Related]  

  • 38. [PROTHROMBIN AND PROCONVERTIN INDICES IN BOTKIN'S DISEASE IN CHILDREN].
    TOLSTOVA TI; PROTOKLITOVA NS
    Vopr Okhr Materin Det; 1964 May; 9():38-41. PubMed ID: 14221572
    [No Abstract]   [Full Text] [Related]  

  • 39. Proconvertin content in the blood of newborn full-term and premature infants.
    VAN CREVELD S; PAULSSEN ; VAN DER MEIJ CA; VERSTEEG P; VERSTEEGH ET
    Etudes Neonatales; 1954 Mar; 3(1):53-61. PubMed ID: 13151165
    [No Abstract]   [Full Text] [Related]  

  • 40. Asolectin separation of prothrombin from proconvertin.
    SEAMAN AJ; OWREN PA
    J Clin Invest; 1956 Apr; 35(4):371-3. PubMed ID: 13306778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.